Erasca (ERAS) Other Accumulated Expenses (2020 - 2026)
Erasca (ERAS) posted Other Accumulated Expenses of $12.1 million for Q1 2026, up 20.92% on a QoQ basis from $10.0 million in Q4 2025, and up 2.31% year-over-year from $11.9 million in Q1 2025.
Erasca (ERAS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Erasca's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $12.1 million for Q1 2026.
- Quarterly Other Accumulated Expenses rose 2.31% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 2.31% YoY) and the FY2025 annual result came in at $10.0 million, down 32.46% from the prior year.
- Other Accumulated Expenses was $12.1 million for Q1 2026 at Erasca, up from $10.0 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $14.9 million in Q4 2024 and bottomed at $113000.0 in Q2 2023.
- A 5-year average of $8.2 million and a median of $10.0 million in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses tumbled 98.94% — and 2025, when it jumped 9631.15%.
- Erasca's Other Accumulated Expenses stood at $11.5 million in 2022, then slipped by 23.6% to $8.8 million in 2023, then jumped by 68.94% to $14.9 million in 2024, then sank by 32.46% to $10.0 million in 2025, then increased by 20.92% to $12.1 million in 2026.
- Business Quant data shows ERAS's Other Accumulated Expenses at $12.1 million in Q1 2026, $10.0 million in Q4 2025, and $11.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Erasca | 5.95 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.15 Mn |
| Dec 31, 2025 | 10.05 Mn |
| Sep 30, 2025 | 11.16 Mn |
| Jun 30, 2025 | 14.37 Mn |
| Mar 31, 2025 | 11.87 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 14.23 Mn |
| Jun 30, 2024 | 396,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 8.80 Mn |
| Sep 30, 2023 | 9.56 Mn |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 11.49 Mn |
| Dec 31, 2022 | 11.52 Mn |
| Sep 30, 2022 | 355,000.00 |
| Jun 30, 2022 | 163,000.00 |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 483,000.00 |
| Sep 30, 2021 | 977,000.00 |
| Jun 30, 2021 | 575,000.00 |